nigericin has been researched along with Alzheimer Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chai, W; Mei, Z; Nie, H; Xiang, Z; Xu, R; Zhang, H; Zhang, J; Zhang, P | 1 |
D'Ascenzo, N; Han, S; He, Z; Hu, X; Jacob, C; Liang, X; Liu, Q; Ni, J; Wan, L; Xiao, P; Xiao, W; Xie, Q | 1 |
Couturier, J; Dewachter, I; Huaux, F; Kienlen-Campard, P; Octave, JN; Pierrot, N; Schakman, O; Stancu, IC | 1 |
3 other study(ies) available for nigericin and Alzheimer Disease
Article | Year |
---|---|
Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.
Topics: Alzheimer Disease; Animals; Cytokines; Disease Models, Animal; Flavones; HMGB Proteins; Humans; Lipopolysaccharides; Mice; Mice, Transgenic; Neuroinflammatory Diseases; Nigericin | 2022 |
Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Line; Disease Models, Animal; Female; Hexokinase; Humans; Indazoles; Interleukin-1beta; Lipopolysaccharides; Mice; Mice, Transgenic; Nigericin; Positron-Emission Tomography; Thiazolidines; Thiones; Up-Regulation | 2021 |
Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Apoptosis Regulatory Proteins; Astrocytes; CARD Signaling Adaptor Proteins; Case-Control Studies; Cells, Cultured; Chemokine CCL3; Cytokines; Disease Models, Animal; Gene Expression Regulation; Humans; Ionophores; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nigericin; Peptide Fragments; Phagocytes; Presenilin-1 | 2016 |